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and Winston-Salem, North CarolinaOBJECTIVES The goal of this study was to assess the association between left atrial (LA) volume and
function measured with feature-tracking cardiac magnetic resonance (CMR) and development of heart
failure (HF) in asymptomatic individuals.
BACKGROUND Whether alterations of LA structure and function precede or follow HF development
remains incompletely understood. We hypothesized that signiﬁcant alterations of LA deformation and
architecture precede the development of HF in the general population.
METHODS In a case-control study nested in MESA (Multi-Ethnic Study of Atherosclerosis), baseline
LA volume and function assessed using CMR feature-tracking were compared between 112 participants
with incident HF (mean age 68.4  8.2 years; 66% men) and 224 age- and sex-matched controls (mean
age 67.7  8.9 years; 66% men). Participants were followed up for 8 years. All individuals were in normal
sinus rhythm at the time of imaging, without any signiﬁcant valvular abnormalities and free of clinical
cardiovascular diseases.
RESULTS Individuals with incident HF had greater maximal and minimal LA volume indexes (LAVImin)
than control subjects (40  13 mm3/m2 vs. 33  10 mm3/m2 [p <0.001] for maximal LA index and 25 
11 mm3/m2 vs. 17  7 mm3/m2 [p <0.001] for LAVImin). The HF case subjects also had smaller global peak
longitudinal atrial strain (PLAS) (25  11% vs. 38  16%; p <0.001) and lower LA emptying fraction (40 
11% vs. 48  9%; p <0.001) at baseline. After adjustment for traditional cardiovascular risk factors, left
ventricular mass, and N-terminal pro–B-type natriuretic peptide, global PLAS (odds ratio: 0.36 per SD
[95% conﬁdence interval: 0.22 to 0.60]) and LAVImin (odds ratio: 1.65 per SD [95% conﬁdence interval:
1.04 to 2.63]) were independently associated with incident HF.
CONCLUSIONS Deteriorations in LA structure and function preceded development of HF. Lower
global PLAS and higher LAVImin, measured using CMR feature-tracking, were independent markers
of incident HF in a multiethnic population of asymptomatic individuals. (J Am Coll Cardiol Img 2014;
7:570–9) ª 2014 by the American College of Cardiology Foundation
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571he majority of individuals in the community
with left ventricular (LV) dysfunction (sys-A B B R E V I A T I O N S
A N D A C R O N YM S
AUC = area under the curve
CI = conﬁdence interval
CMR = cardiac magnetic
resonance
EF = ejection fraction
HF = heart failure
HFNEF = heart failure with
normal ejection fraction
LA = left atrium
LAV = left atrial volume
LAVmax = maximum left atrial
volume
LAVmin = minimum left atrial
volume
LAVI = left atrial volume index
LAVPreA = pre–atrial contraction
left atrial volume
LV = left ventricle
NT-proBNP = N-terminal pro–B-
type natriuretic peptide
OR = odds ratio
PLAS = peak longitudinal
atrial strain
preA-S = longitudinal strain
before atrial contractiontolic or isolated diastolic) are in the preclinical
phase of heart failure (HF) (1). Methods to
assess the risk of progression to symptomatic HF
would be clinically valuable. Left atrial (LA) size is a
known prognostic marker in multiple conditions
such as HF (2–5), myocardial infarction (6), atrial
ﬁbrillation (7), and thromboembolic events (8,9).
More recently, evidence for LA function being a
prognostic indicator in the outcome of cardiovas-
cular diseases has emerged (10–13).
The left atrium acts as a reservoir during systole,
as a conduit during early diastole, and works as an
active pump during late diastole. During diastole,
the left atrium and the left ventricle are directly
connected and, in the absence of valvular disease,
LA and LV function are tightly coupled.
There are several established methods for non-
invasive evaluation of LA volume such as using
2- or 3-dimensional echocardiography (14,15),
speckle-tracking echocardiography (16), dual-source
computed tomography (17), or cardiac magnetic
resonance (CMR) (15,18,19). LA strain assess-
ment has previously been mainly performed using
speckle-tracking echocardiography (9,16,20).
However, given the thin LA wall, the use of
speckle-tracking echocardiography can be a chal-
lenging technique for the assessment of LA func-
tion. CMR has therefore been proposed as the
gold standard modality to measure atrial and
ventricular volumes (18). CMR is also an estab-
lished method for measurements of cardiac defor-
mation given its excellent ability to deﬁne
endocardial and epicardial borders for adequate strain
analysis. CMR feature-tracking has been described
recently as an accurate method of wall motion
assessment (21–23). However, to our knowledge,
CMR feature-tracking has not been used for LA
strain or volume evaluation in individuals at risk of
developing HF. The present study was performed in
a large multiethnic population to assess the associa-
tion between LA function and subsequent HF
development. We hypothesized that reduced LAFrom the *Cardiology Division, Department of Medicine, Johns Hopkins
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would be associated with a higher incidence of HF.
MATER IALS AND METHODS
Study design. The present study was designed as a
nested case-control study within MESA (Multi-
Ethnic Study of Atherosclerosis). The MESA study
protocol has previously been described in detail (24).
Brieﬂy, between July 2000 and August 2002, a total
of 6,814 individuals between 45 and 84 years of age
from 4 different self-reported ethnic backgrounds
(white, African-American, Hispanic, and Chinese)
were enrolled. These individuals were
recruited from 6 U.S. communities in
California, Illinois, Maryland, Minnesota,
New York, and North Carolina. All par-
ticipants were free of any clinically appa-
rent cardiovascular disease.
To evaluate cardiac structure and func-
tion, 5,004 individuals (73.4%) underwent
CMR at baseline. CMR was performed
using 1.5-T magnets; the full CMR pro-
tocol and methods of analysis have been
described previously (25).
Follow-up. Every 6 to 9 months, a tele-
phone interviewer contacted each partici-
pant to ask about hospital admissions,
cardiovascular outpatient diagnoses, and
deaths. Medical records and information
were successfully obtained on an estimated
98% of reported hospitalized cardiovascu-
lar events and 95% of reported outpatient
cardiovascular diagnostic encounters.
Identiﬁcation of case and control subjects. The
endpoint in this study was incident symp-
tomatic HF. Cases of HF in MESA have
been classiﬁed as deﬁnite or probable. Both
types required HF symptoms and/or signs
such as dyspnea or edema. In addition to these
criteria, deﬁnite HF also required at least 1
other ﬁnding such as pulmonary edema or congestion
according to chest radiograph, dilated ventricle or poor
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572or evidence of LV diastolic dysfunction. Probable HF
required a physician diagnosis of HF and medical
treatment for HF. After 8 years of follow-up, 112 cases
of probable and deﬁnite HF who had available CMR
data at baseline were identiﬁed and entered into the
study as the case subjects (Fig. 1). Based on the
measured LV ejection fraction (EF) at the time of the
HF diagnosis, cases were categorized into systolic HF or
heart failure with normal ejection fraction (HFNEF) if
the measured EF was <50% or $50%, respectively.
For each case subject, 2 control subjects matched
for age and sex were randomly selected from the
5,004 participants who had CMR performed at
baseline (Fig. 1).
Covariates. Standardized questionnaires were used
at baseline to collect information about age, sex,
ethnic background, cigarette smoking, use of anti-
hypertensive medication, or high cholesterol. Ciga-
rette smoking was categorized to current, former, or
never. Body mass index was calculated as weight
divided by height squared (kg/m2) from weight
measured to the nearest 0.5 kg and height to the
nearest 0.1 cm. Blood pressure was measured 3 times
using a Dinamp model Pro 100 automated oscillo-
metric sphygmomanometer (Critikon, Inc., Tampa,
Florida) while the participants were resting in a seated
position. The average of the last 2 measurements was
used in the analysis. Fasting blood glucose and total
and high-density lipoprotein cholesterol levels wereFigure 1. Flow Chart of the Study
A nested case-control study with 112 case and 224 control sub-
jects. HF ¼ heart failure; LA ¼ left atrial; MESA ¼Multi-Ethnic Study
of Atherosclerosis; MRI ¼ magnetic resonance imaging.measured after fasting for 12 h. Fasting glucose was
obtained by a thin-ﬁlm adaptation of the glucose
oxidase method (Johnson & Johnson Clinical
Diagnostics, Inc., Rochester, New York). Diabetes
was deﬁned as a fasting glucose level $126 mg/dl or
use of hypoglycemic medication. N-terminal pro–
B-type natriuretic peptide (NT-proBNP) was
analyzed centrally at a core laboratory (University of
Vermont, Burlington, Vermont).
Image analysis. We used multimodality tissue
tracking (MTT) software version 5.0 (Toshiba,
Tokyo, Japan) to obtain LA strain and volume quan-
tiﬁcation from baseline 4-chamber and 2-chamber
cine CMR images. A single experienced operator
places points along the endocardial and epicardial
borders in the left atrium. Using the marked points,
the software draws endocardial and epicardial borders
and then searches for the most closely matching bor-
ders in the subsequent frames. The operator then
follows endocardial and epicardial contours generated
by the software during the cardiac cycle for quality
control. Maximum, minimum, and pre-atrial con-
tracture LA volumes were measured using the area–
length method from apical 4-and 2-chamber views
(Fig. 2). All measured LA volumes were subsequently
indexed according to body surface area. The parame-
ters of LA volume included in our study were:
 Maximum LA volume (LAVmax): LA volume at
end systole before mitral valve opening.
 Minimum LA volume (LAVmin): LA volume at
end diastole right after mitral valve closure.
 Pre–atrial contraction LA volume (LAVPreA):
LA volume before atrial contraction.
 Conduit volume: LAVmax – LAVPreA.
 Conduit volume fraction: 100  (LAVmax –
LAVPreA)/LAVmax.
 Total LA emptying fraction: 100  (LAVmax –
LAVmin)/LAVmax.
Strain measurement. The software generates lon-
gitudinal strain curves for each atrial wall segment as
shown in Figure 3. Global longitudinal atrial strain
was generated by averaging all LA segmental values
at each time frame. Global peak longitudinal atrial
strain (PLAS) and longitudinal strain before atrial
contraction (preA-S) were measured from the global
longitudinal strain curve.
Validation of volume measurements using MTT
software. To validate the measured volumes
according to MTT software, using the same CMR
images, we also measured minimum and maximum
LA volumes using the area–length method in all
case and control subjects. Image analysis was per-
formed on a Windows workstation using QMass
Figure 2. Tracking LA Wall Motions Using Cine CMR Images
Multidisciplinary tissue tracking software was used on untagged cine cardiac magnetic resonance (CMR) images in 2-chamber and 4-chamber
views to track LA wall motions in systole and diastole. Abbreviations as in Figure 1.
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573software version 7.0 (Medis Medical Imaging Sys-
tems BV, Leiden, the Netherlands). To measure
LA area, endocardial contours were drawn in the
left atrium in end systole and diastole. The longi-
tudinal axis of the left atrium was deﬁned by
measuring the distance from the center of the mitral
valve annulus to the posterior LA wall (Fig. 4). We
used the biplane area–length formula to measure the
LA volumes: volume ¼ (0.848 $ area4ch $ area2ch)/
([length2ch þ length4ch]/2) (15).
Statistical analysis. Continuous variables are pre-
sented as mean  SD. Categorical variables are
presented as frequencies and percentages. Differ-
ences between group means were evaluated with
Student t tests (continuous variables) or chi-square
analysis (categorical variables) as appropriate. Log-
arithmic transformation was applied to NT-
proBNP before entry into the models because of
its skewed distribution. Nonconditional logistic
regression was used to calculate odds ratios (ORs)
and the corresponding 95% conﬁdence intervals
(CIs) in 3 models. Model 1 was adjusted for age,
sex, ethnicity, body mass index, diabetes mellitus,
cigarette smoking, systolic blood pressure, heartrate, total cholesterol, and high-density lipoprotein
levels (traditional cardiovascular risk factors). In
model 2, an additional adjustment was made for
LV mass. We additionally added NT-proBNP
into model 3. We adjusted for LV mass and
NT-proBNP because both markers have been
shown to be associated with incident HF (26,27). In
addition, these 2 variables are well-known markers
of volume or pressure overload in the left ventricle
that directly affect LA volume and function (28,29).
Receiver-operating characteristic curves were
generated to assess the overall performance of these
3 models and LA parameters in predicting HF.
Area under the curve (AUC) derived from receiver-
operating characteristic curve analysis were calcu-
lated and compared using a previously described
method from DeLong et al. (30).
Interobserver and intraobserver reproducibility for
LA parameters were assessed in 20 randomly
selected subjects from the case and control groups.
Two readers (M.H. and a trained lab technologist
with 10 years of experience in CMR data analysis)
remeasured LA parameters using the same
method. The readers were blinded to the other
Table 1.
Non-HF C
Age, yrs
Male
Ethnicity
White
Chinese
Black
Hispani
Systolic b
Diastolic b
Heart rate
Body mas
Current sm
Total cho
HDL chol
Diabetes
LV ejectio
LV mass i
Values are
HDL ¼ hi
Table 2. Left Atrial Parameters in HF Case Subjects and
Non-HF Control Subjects
Non-HF Controls
(n [ 224)
HF Cases
(n [ 112) p Value
LAVmax, ml 60  21 77  25 <0.001
LAVImax, ml/m
2 33  10 40  13 <0.001
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574measurements. Also in the same sample, LA pa-
rameters were remeasured by the original reader
blinded to the ﬁrst measurement. Intraclass corre-
lation coefﬁcient analysis was performed to evaluate
interobserver and intraobserver agreement. All sta-
tistical analyses were performed using Stata software
version 11.2 (Stata Corp., College Station, Texas).LAVmin, ml 32  14 48  22 <0.001
LAVImin, ml/m
2 17  7 25  11 <0.001
LAEF, % 48  9 40  11 <0.001
CVEF, % 23  8 17  8 <0.001
Global PLAS, % 38  16 25  11 <0.001
PreA-S % 23  11 16  8 <0.001
Values are mean  SD.
CVEF ¼ conduit volume fraction; LAEF ¼ left atrial emptying fraction;
LAVmax ¼ left atrial maximum volume; LAVmin ¼ left atrial minimum volume;
LAVImax ¼ left atrial maximum volume index; LAVImin ¼ left atrial minimum
volume index; PLAS ¼ peak longitudinal atrial strain; preA-S ¼ longitudinal
strain before atrial contraction; other abbreviations as in Table 1.RESULTS
It was feasible to measure LA function parameters
in 100 (89%) and 192 (86%) case subjects and
control subjects, respectively (Fig. 1). The differ-
ences in baseline characteristics of incident HF case
subjects and non-HF control subjects have been
summarized in Table 1. Incident HF case subjects
had higher systolic blood pressure, body mass index,
and heart rate at baseline. Hypertension, diabetes
mellitus, and cigarette smoking were also more
common at baseline in incident HF cases.
LA volumes. LA volume measurements in case and
control subjects are summarized in Table 2. Baseline
LAVmax was higher in incident HF patients com-
pared with control subjects (77  25 ml in case sub-
jects vs. 60  21 ml in control subjects; p < 0.001).
LAVmin and LAVPreA indexes were also signiﬁcantly
higher in HF case subjects than in control subjects.Baseline Characteristics of HF Case Subjects and
ontrol Subjects
Non-HF Controls
(n [ 224)
HF Cases
(n [ 112) p Value
67.7  8.9 68.4  8.2 0.517
66.5 66.7
0.035
38.1 42.9
15.1 4.5
25.7 31.2
c 21.1 21.4
lood pressure, mm Hg 130  23 138  21 0.005
lood pressure, mm Hg 73  11 73  11 0.878
, beats/min 62  10 66  11 0.005
s index, kg/m2 27.2  4.2 28.8  5.0 0.002
oker 11 19 0.012
lesterol, mg/dl 190  33 190  35 0.970
esterol, mg/dl 49  15 49  14 0.735
14 30 <0.001
n fraction 69  8 64  12 <0.001
ndex, g/m2 148  39 187  58 <0.001
mean  SD or %.
gh-density lipoprotein; HF ¼ heart failure; LV ¼ left ventricular.LA strain. Incident HF patients had a signiﬁcantly
lower global PLAS at baseline compared with
control subjects (25  11% vs. 38  16%, respec-
tively; p < 0.001). Global preA-S was also lower in
HF cases (16  8% in case subjects vs. 23  11% in
control subjects; p < 0.001). Among all case and
control subjects, all those with global PLAS <14%
developed HF during the 8-year follow-up period.
Association of LA function and HF. The relationship
between LA volumes and incident HF was tested in
logistic regression models. Table 3 summarizes ORs
(95% CIs) associated with measured LA parameters
and incident HF. In model 1 (adjusted for tradi-
tional risk factors), all LA parameters were signiﬁ-
cantly associated with development of HF. Among
the volume measurements, the LAVmin index had
the highest OR (2.75 [95% CI: 1.9 to 4.0]). Low
LA emptying fraction, conduit volume fraction, and
peak and preA-S at baseline were also associated
with higher incidence of HF; global PLAS had the
strongest OR (0.28 [95% CI: 0.18 to 0.44]). In
model 2, the results were similar after additionally
adjusting for the LV mass index. Both strain mea-
surements remained signiﬁcantly associated with
HF development in model 3, with global PLAS
having the strongest OR (0.36 [95% CI: 0.22
to 0.60]). However, in model 3, after adding log
NT-proBNP to the model, the only statistically
signiﬁcant volume measurement associated with
HF was the LAVmin index (OR: 1.65 [95% CI:
1.04 to 2.63]).
To further explore the value of LA function inHF,
we performed receiver-operating curve analyses.
We added all left atrium–measured parameters to
Table 3. Left Atrial Function and Incident HF
Odds Ratio* (95% CI)
Model 1y Model 2z Model 3x
LAVImax, ml/m
2 2.09 (1.50–2.89) 1.72 (1.22–2.43) 1.46 (0.96–2.27)
LAVImin, ml/m
2 2.75 (1.89–3.99) 2.17 (1.46–3.21) 1.65 (1.04–2.63)
LAEF, % 0.38 (0.27–0.55) 0.48 (0.33–0.71) 0.68 (0.45–1.03)
LACV, % 0.48 (0.34–0.67) 0.59 (0.42–0.83) 0.69 (0.46–1.03)
Global PLAS, % 0.28 (0.18–0.44) 0.35 (0.22–0.55) 0.36 (0.22–0.60)
PreA-S, % 0.37 (0.25–0.57) 0.44 (0.30–0.67) 0.48 (0.30–0.77)
*Odds ratios are presented per SD change in measurements. yModel 1 was adjusted for age,
sex, ethnicity, heart rate, body mass index, diabetes mellitus, systolic blood pressure, total
cholesterol, high-density lipoprotein, and cigarette smoking. zModel 2 was additionally
adjusted for LV mass. xModel 3 was additionally adjusted for log N-terminal pro–B-type
natriuretic peptide.
CI ¼ conﬁdence interval; LACV ¼ left atrial conduit volume fraction; other abbreviations as
in Tables 1 and 2.
Table 4. AUC for LA Parameters According to HF Development
AUC p Value
Base model 0.71 d
Base model þ LAVImax 0.77 0.029
Base model þ LAVImin 0.79 0.003
Base model þ LAEF 0.79 0.006
Base model þ LACV 0.77 0.013
Base model þ preA-S 0.79 0.005
Base model þ PLAS 0.81 <0.001
AUC ¼ area under the curve; LA ¼ left atrial; other abbreviations as in
Tables 1 to 3.
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575traditional risk factors for HF development
(Table 4). The AUC was highest for PLAS and
traditional risk factors compared with traditional
risk factors alone (0.81 vs. 0.71, respectively; p ¼
0.004). We also compared the AUC by incre-
mentally adding LV mass index, NT-proBNP, and
global PLAS to traditional risk factors in Table 5.
Compared with traditional risk factors alone, AUC
values for HF development showed the greatest
augmentation after incremental addition of the LV
mass index, log NT-proBNP, and global PLAS in
the overall case and control populations (0.76 vs.
0.71 [p ¼ 0.04], 0.82 vs. 0.76 [p < 0.001], and
0.86 vs. 0.82 [p < 0.001], respectively).
Systolic HF versus HF with normal EF. Of 112 cases,
98 had measured EF at the time of HF diagnosis.
Thirty-nine cases (39.8%) developed HFNEF, and
59 (60.2%) developed systolic HF. LA parameters
at baseline did not differ between these 2 categories
(Table 6).
Reproducibility of LA variables using MTT software.
Reproducibility of LA measurements was evaluated
in 20 randomly selected subjects. Intraclass corre-
lation coefﬁcients were 0.95 and 0.97 for LAVmax,
0.92 and 0.93 for LAVmin, 0.92 and 0.95 for
global PLAS, and 0.90 and 0.91 for preA-S for
interobserver and intraobserver reproducibility,
respectively.
Measured LA volumes using area–length method
compared with use of MTT software. LAVmin and
LAVmax were similar when measured using the
area–length method compared with those obtained
using MTT software. The mean LAVmax and
LAVmin were 66.5  24.0 ml and 37.0  18.6 ml
when measured using MTT software compared
with 69.5  24.6 ml and 38.9  18.9 ml when
measured using the area–length method, respec-
tively. Intraclass correlation coefﬁcients were 0.94
(95% CI: 0.92 to 0.97) for LAVmax and 0.91 (95%
CI: 0.87 to 0.95) for LAVmin.
D I SCUSS ION
This nested case-control study performed within a
large longitudinal multiethnic population of asymp-
tomatic individuals demonstrated a strong associa-
tion between altered LA deformation as measured
using CMR feature-tracking and HF development.
We found that individuals who develop HF have
reduced global PLAS and increased LAVmin index
well before the onset of symptomatic clinical mani-
festation. In our study, this association was inde-
pendent of traditional cardiovascular risk factors,
LV mass, and NT-proBNP. These ﬁndingsemphasize the role of LA dysfunction in identifying
asymptomatic individuals at higher risk for HF
development. Given the fact that LVEF is normal
in more than one-half of HF patients (31), the
assessment of LA function is valuable in the evalua-
tion of LV diastolic performance. Although the left
atrial volume index (LAVI) measurement is now
included as a parameter in the European Society of
Cardiology guidelines to diagnoseHFwith preserved
EF (32), no measures of LA mechanical behavior
have so far been proposed as markers of risk for this
condition.
In most previous studies, 2-dimensional echo-
cardiography has been used for volume measure-
ments of the left atrium. However, CMR has been
shown to have excellent reproducibility and accuracy
in the measurement of cardiac volumes, making it
the gold standard modality for the assessment of
cardiac chambers (33). One study comparing LA
volume measured using CMR and echocardiogra-
phy showed that echocardiography consistently
underestimated volumes compared with CMR (19).
Table 5. AUC According to Incident HF
AUC p Value
Base model 0.71 d
Base model + LV mass 0.76 0.04
Base model + LV mass + NT-proBNP 0.82 <0.001
Base model + LV mass + NT-proBNP + PLAS 0.86 <0.001
p values are for comparisons of each model with the base model.
NT-ProBNP ¼ N-terminal pro–B-type natriuretic peptide; other abbreviations
as in Tables 1, 2, and 4.
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576To our knowledge, CMR has never been used to
assess LA strain as a prognostic marker in HF. In
this study, we demonstrated the value of CMR
feature-tracking to assess LA function, including
volumes and strain.
LA volume and HF. Recently, there has been
emerging evidence supporting the prognostic role of
LA volume in predicting incident HF (5,34,35).
Takemoto et al. (5) showed that LAVI $32 ml/m2
in elderly adults referred for echocardiography was
independently associated with higher incident HF
(hazard ratio: 1.97; 95% CI: 1.4 to 2.7). In another
large prospective study, older (>65 years of age)
individuals who developed HF during follow-up had
a higher LA linear diameter at baseline (34). Also, in
another population study, LAVI, as measured using
echocardiography, was associated with the severity of
diastolic dysfunction after adjusting for age, sex,
presence of cardiovascular disease, EF, and LV mass
index (36). In these studies, the associations of LAVI
were tested only after adjustment for several covari-
ables but not for NT-proBNP. In our study, all
volume measurements were still signiﬁcantly asso-
ciated with HF after adjusting for traditional risk
factors and LV mass index. However, after adjusting
for NT-proBNP, only the LAVmin index was inde-
pendently associated with HF. Our ﬁndingsTable 6. LA Parameters at Baseline in Individuals With HF and
HFNEF and Those With Systolic HF
Systolic HF
(n [ 59)
HFNEF
(n [ 39) p Value
LAVImax, ml/m
2 39.4  11.7 40.8  13.9 0.61
LAVmin index, ml/m
2 24.4  9.6 24.5  11.2 0.99
LAEF, % 38.3  9.5 42.3  11.5 0.09
LACV, % 16.5  7.1 18.2  7.3 0.27
Global PLAS, % 23.2  9.6 26.3  13.2 0.20
PreA-S, % 14.44  6.4 17.99  9.9 0.053
Values are mean  SD.
HFNEF ¼ heart failure with normal ejection fraction; other abbreviations as
in Tables 1 to 3.complement 2 other studies emphasizing the asso-
ciation of LAVmin and LV dysfunction. In 1 study of
patients with HFNEF, Russo et al. (37) demon-
strated that the LAVmin increases even in mild dia-
stolic dysfunction, whereas an increase in LAVmax
was only seen in later stages of systolic dysfunction.
In the other study of 41 patients undergoing cardiac
catheterization, among the LA volumes, LAVmin
was the most sensitive identiﬁer of LV end-diastolic
pressure (38).
We found no statistically signiﬁcant differences
in baseline LA parameters between cases with sys-
tolic HF versus those with HFNEF. It has been
shown previously that patients with HFNEF have
larger LA volumes and reduced total, passive, and
active LA emptying fractions (4,37). LA function is
also reduced with exercise in patients with HFNEF
compared with asymptomatic hypertensive and
healthy individuals (39). However, to our knowl-
edge, this is the ﬁrst study comparing LA function
between individuals with systolic HF and HFNEF
before symptomatic HF development.
LA strain and HF. Global PLAS has been proposed
as a useful parameter in the assessment of LA
function (40,41). This parameter reﬂects the passive
stretching of the left atrium during LV systole and
represents LA compliance and reservoir function. It
has also been previously demonstrated that global
PLAS correlates strongly with LV ﬁlling pressure
(20,42). In 1 study involving 36 patients with sys-
tolic HF, among all parameters of LA function,
global PLAS was the strongest predictor of elevated
pulmonary capillary wedge pressure with an AUC of
0.93 and a sensitivity and speciﬁcity of 100% and
93%, respectively, using a cutoff value <15.1% (20).
LA strain has also been associated with cardiovas-
cular outcomes other than HF. In previous studies,
LA strain measured using speckle-tracking echo-
cardiography has been associated with the risk of
new-onset atrial ﬁbrillation (43) and stroke (44).
Also, in a previous longitudinal study of 312 adults
with a mean follow-up of 3.1  1.4 years, global
PLAS was the strongest predictor of cardiovascular
outcomes (45). Our results therefore are consistent
with these previous ﬁndings, as global PLAS mea-
sured using CMR feature-tracking was the strongest
parameter of LA performance associated with
incident HF in this multiethnic population of
asymptomatic individuals.
Study limitations. The strengths and limitations of
our study include being a longitudinal study with
8 years of follow-up in asymptomatic individuals
from a multiethnic population. Other strengths in-
clude a wide age range of the study population, in
Figure 3. Volume and Strain Curves
Volume/time (left) and strain/time (right) curves showing atrial volume and global longitudinal strain at different phases.
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577contrast to most other studies on LA function, and
also availability of comprehensive and standardized
clinical data as well as biomarkers. To our knowl-
edge, our study is among the ﬁrst to measure LA
strain using CMR.
Several study limitations should also be noted.
The design was a nested case-control study. How-
ever, we matched our control group for age and sex,Figure 4. Measuring LA Volume Using the Area–Length Method
Maximum and minimum LA areas along with longitudinal and transver
(right) views. Abbreviation as in Figure 1.and our statistical analysis was adjusted for possible
confounders. This was a relatively small study, with
112 case subjects (100 with analyzable images) and
224 control subjects (192 with analyzable images).
However, based on the study by Morton et al. (23),
a sample size of 29 has 90% power and an alpha
error of 0.05 to detect a change of 5% in strain.
Although feature-tracking CMR in our study had ase diameters were measured in the 2-chamber (left) and 4-chamber
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578great interobserver and intraobserver reproducibility,
its test–retest variability in the measurement of LA
function was not examined. Given the thin wall of
the left atrium, the CMR images were not inter-
pretable in about 13% of the study population due to
the failure in LA wall tracking. Nevertheless, this
rate is comparable to, or lower than the rate in other
studies using speckle-tracking echocardiography in
measurements of LA function (4,16).
CONCLUS IONS
Among this diverse population with no symptomatic
cardiovascular disease, there was an independent
inverse association between global LA longitudinal
strain measured using CMR and incident HF.
Among the LA volume measurements, only LA
minimal volume index was independently associated
with incident HF. Moreover, our study demon-
strated that measurements of LA longitudinal
strain and volumes using CMR feature-tracking are
feasible and reproducible in population studies.
Our study, which was performed using CMR as anaccurate but expensive modality for the assessment of
myocardial wall motion, complements previous
studies performed with echocardiography. Our
ﬁndings emphasize the importance of LA function,
especially global PLAS and LAVImin, in HF devel-
opment among asymptomatic healthy individuals.
Further studies investigating the longitudinal
changes in LA function would be helpful for quan-
tifying the independent prognostic power of LA
function in predicting HF.Acknowledgments
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